BiotechTube
Home/RNAimmune/Zhifeng (Steven) Long
Z(

Zhifeng (Steven) Long

Chief Science Officer

RNAimmune

Therapeutic Areas

OncologyInfectious DiseasesRare Diseases

RNAimmune Pipeline

DrugIndicationPhase
RV-1770Respiratory Syncytial Virus (RSV) ProphylaxisPhase 1
RV-1730COVID-19 BoosterPhase 1
mRNA Cancer VaccinesOncology (Neoantigen-based)Pre-clinical

Leadership Team at RNAimmune

DS
Dong Shen
Chief Executive Officer
View full RNAimmune profile